Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

3264 - Non-elective admissions in cancer care - A review of Acute Oncology Services (AOS) implementation in a North-West region of England

Date

10 Sep 2017

Session

Poster display session

Presenters

Shien Chow

Citation

Annals of Oncology (2017) 28 (suppl_5): v395-v402. 10.1093/annonc/mdx375

Authors

S. Chow, R. Leach, C. Mitchell

Author affiliations

  • Medical Oncology, The Christie NHS Foundation Trust, M20 4BX - Manchester/GB
More

Resources

Abstract 3264

Background

Parallel to advances in cancer therapeutics in the clinics, high quality and patient-centred management of cancer or treatment-related complications during non-elective attendance especially to a non-specialist hospital is crucial in achieving excellent patient outcome. AOS was innovated in the UK to meet this need and has rapidly expanded in recent years. Here, we describe findings of an on-going audit of this expanding networked service within Greater Manchester and Cheshire East County consisting of 10 district general hospitals in collaboration with a regional specialist cancer centre (The Christie NHS Foundation Trust).

Methods

Information related to any hospital episodes warranting AOS input was collated from all participating hospitals using standardised proforma and analysed.

Results

Between Jan 2015 - Sep 2016, 7638 non-elective hospital attendances were recorded of which 58% occurred within working hours. Common cancer sites were lung 16%, breast 15%, lower GI 12%, urology 12%, upper GI and HPB 9%, haematology 7%, gynaecology 6%, cancer of unknown primary(CUP) 6%, and others 7%. Majority were related to cancer complication 40% (Type III), treatment - related 32% (Type II), new cancer diagnosis 10% (Type I) and others 17%. 94% of AOS involvement occured within 24hr of attendance. Level of intervention by AOS was considered major in 60% while 30% and

Conclusions

This large multi-sites audit documented the service delivery pattern of a growing oncology subspecialty at the same time provided a glimpse into the healthcare implication of unplanned admission in the current era of advancing oncology lanscape. Excellent median LOS in this region compared to national average likely a reflection of pertinent AOS team involvement in a timely manner. AOS is now an integral component to the cancer care in the UK and its role in the non-elective setting serves to ensure excellent patient experience as well as providing far-reaching potential in healthcare efficiciency.

Clinical trial identification

not applicable

Legal entity responsible for the study

not applicable

Funding

None

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.